Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$0.11+0.00 (+1.81%)
Close on Oct 19, 2026Market cap $21.99MP/E –Yield –
Cellyan Biotechnology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cellyan Biotechnology's pe ratio was 130.0× on May 30, 2025.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | May 30, 2025 | 130.0× | – |
See a number that looks wrong?